Shandong Dongyue Organosilicon Materials Co., Ltd.

XSEC:300821 Stock Report

Market Cap: CN¥10.4b

Shandong Dongyue Organosilicon Materials Past Earnings Performance

Past criteria checks 2/6

Shandong Dongyue Organosilicon Materials's earnings have been declining at an average annual rate of -26%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 17.4% per year. Shandong Dongyue Organosilicon Materials's return on equity is 2.1%, and it has net margins of 2%.

Key information

-26.0%

Earnings growth rate

-29.9%

EPS growth rate

Chemicals Industry Growth12.1%
Revenue growth rate17.4%
Return on equity2.1%
Net Margin2.0%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Shandong Dongyue Organosilicon Materials makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

XSEC:300821 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 245,21510370169
30 Jun 245,055-1468179
31 Mar 244,823-15674205
31 Dec 234,801-27173234
30 Sep 235,163-35484278
30 Jun 235,715-19981302
31 Mar 236,78920085316
01 Jan 236,73451188317
30 Sep 226,64595241301
30 Jun 226,1821,29964292
31 Mar 224,9661,26971263
31 Dec 214,3331,15179232
30 Sep 213,600946127226
30 Jun 213,002567119222
31 Mar 212,638349118212
31 Dec 202,503281114186
30 Sep 202,37220793159
30 Jun 202,499324118118
31 Mar 202,62652512393
31 Dec 192,73355312186
30 Sep 192,93856719365
30 Jun 193,00152821763
31 Mar 193,19452321350
31 Dec 183,40166321645
31 Dec 172,4413101003
31 Dec 161,69261932
31 Dec 151,454-35772

Quality Earnings: 300821 has high quality earnings.

Growing Profit Margin: 300821 became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300821's earnings have declined by 26% per year over the past 5 years.

Accelerating Growth: 300821 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 300821 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (-5.3%).


Return on Equity

High ROE: 300821's Return on Equity (2.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies